You are not connected. The newsletter may include some user information, so they may not be displayed correctly.

ASCIA Update 6 November 2023

ASCIA Update 6 November 2023

‍‍ ‍ ‍ ‍Click here to view it online

ASCIA Update

ASCIA Update 6 November 2023


ACECQA Approved ASCIA Anaphylaxis E-training

ASCIA anaphylaxis e-training for children's education and care services has been approved by the Australian Children's Education and Care Quality Authority (ACECQA) until October 2026. ACECQA is an independent statutory authority that assists governments in implementing the National Quality Framework for early childhood education and care throughout Australia. The content of the previous version of the ASCIA course was ACECQA approved until the end of September 2023

Read more here



ASCIA Food Allergy and Adverse Food Reactions Course for Dietitians

Registration is still open to all dietitians for the ASCIA Food Allergy and Adverse Food Reactions Course, which is being held for the first time in Sydney, on Thursday 23 and Friday 24 November 2023. This course has an interactive in-person program that is focussed on medical nutrition therapy in food allergy and intolerance.

Information about the course and how to register is available here



Survey to Improve Allergy Training in Tertiary Healthcare Degrees

People who are involved in the development and delivery of tertiary healthcare degrees in Australia are invited to complete a survey about allergy training. ASCIA is conducting this survey as part of the National Allergy Council Shared Care for Allergy Project.

The survey is available here



Product Availability – Recent Updates

Jorveza® is an orally disintegrating budesonide tablet for the treatment of eosinophilic oesophagitis (EoE). Changes to the PBS criteria have been made to improve access, effective November 2023. Read more here

Shingrix® is a varicella zoster virus recombinant vaccine that can provide protection from herpes zoster (shingles) and post-herpetic neuralgia. Shingrix is now funded for many Australians from November 2023. Read more here

Dymista® Allergy is an antihistamine and corticosteroid combination nasal spray for treatment of allergic rhinitis (hayfever), which is now available over-the-counter (OTC) in Australia. Read more here



Allergy and Immunology Research Grants and Awards

Donate here to support more AIFA allergy and immunology research grants in 2024. All donations go directly to fund AIFA research grants. 

Apply here for the Stallergenes Greer Foundation Science Awards (by 29 November 2023) for young or mid-career scientists working in allergy.

Apply here for the Grifols ASPIRE Award (by 31 March 2024) for research projects that improve immunodeficiency awareness, diagnosis and therapy.



Reminder: Department of Health Consultation

ASCIA members are welcome to be involved in the following Australian government Department of Health consultation:

National Nursing Workforce Strategy – Submissions close 28 November 2023



Recent ASCIA Allergy Updates

New ASCIA Management Plan for Delayed Allergic Reactions to Foods

New ASCIA Venom Immunotherapy (VIT) FAQ and consent form

Updated ASCIA Treatment Plan for Allergic Rhinitis

Updated ASCIA Allergen Immunotherapy (AIT) FAQ and consent form

Updated ASCIA Travel Plan for People at Risk of Anaphylaxis

Updated ASCIA Guide for Milk Substitutes in Cow’s Milk Allergy



Recent ASCIA Immunodeficiency and Autoimmunity Updates

New Subcutaneous Immunoglobulin (SCIg) products

New Transition from Evogam to Hizentra AU SCIg products

New ASCIA Laboratory Tests for Autoimmune Diseases Position Paper

Updated ASCIA IVIg Infusion Guidelines

Outcomes from ASCIA Immunodeficiency Strategy Meeting  



Regularly Updated ASCIA Webpages

ASCIA Conference Report

ASCIA Reports

ASCIA Submissions

Allergy/Immunology Positions

Locate a Specialist

Conference, Meetings and Events Calendar


ASCIA gratefully acknowledges the generous support of all sponsors listed on the ASCIA website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand.  

ASCIA Updates provide current information to the community about allergy and other immune system disorders.


AIFA is dedicated to improving the health of people with allergy and other immune system disorders by providing AIFA allergy and immunology research grants. 

‍‍ ‍ ‍ ‍ ‍ ‍Unsubscribe to ASCIA Update